MedPath

axunio Pharma GmbH

🇩🇪Germany
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

10

EMC:7
CIMA_AEMPS:2
EMA:1

Drug Approvals

Pirfenidone axunio (previously Pirfenidone AET)

Authorization Status
Authorised
Approval Date
Jun 20, 2022
EMA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.